These data indicate that increased expression of SIRT1 may be a predictor of worse overall survival (OS) in patients with gastric cancer, whereas reduced SIRT1 may be a predictor of worse OS in patients with rectal cancer (Figure 3). The gene discussed is SIRT1; the disease is gastric cancer.